Literature DB >> 24919594

Efficient diagnosis of Sjögren's syndrome to reduce the burden on patients.

Asumi J Niikura1, Shigeo Yamachika, Ken Yamamoto, Mariko R Okamoto, Yuko F Ikeda, Sachika Nakamura, Etsuko Oda, Takahiro K Imamura, Ichiro Saito, Yoichi Nakagawa.   

Abstract

OBJECTIVE: The purpose of this study was to investigate the procedures for efficiently diagnosing Sjögren's syndrome to reduce patient burden.
METHODS: This study analyzed data from 254 Japanese patients diagnosed with Sjögren's syndrome out of 4967 who visited our clinic complaining of xerostomia.
RESULTS: Of the 254 Sjögren's syndrome patients, 140 fulfilled the criteria proposed by the Committee on Sjögren's Syndrome of the Ministry of Health and Welfare of Japan, 228 fulfilled the criteria proposed by the American-European Consensus Group, and 69 fulfilled the criteria proposed by the American College of Rheumatology. Numbers of definitive cases varied with each set of criteria. Logistic regression analysis was used to analyze useful examination items for definitive diagnosis of Sjögren's syndrome, demonstrating that anti-Ro/SSA (odds ratio (OR), 7.165), lip biopsy (OR, 4.273), sialography (OR, 2.402), and ANA (OR, 0.678) correlated significantly with definitive diagnosis of Sjögren's syndrome.
CONCLUSIONS: These results suggest that the following diagnostic procedure for Sjögren's syndrome would reduce burden on patients. When clinicians choose examination items for diagnosing Sjögren's syndrome, they should first select which criteria to use. Then, to minimize the number of examination items, examinations should be performed in order of anti-SSA antibody, lip biopsy, and parotid gland sialography.

Entities:  

Keywords:  Anti-SS-A antibody; Diagnostic criteria; Lip biopsy; Parotid sialography; Sjögren's syndrome

Mesh:

Substances:

Year:  2014        PMID: 24919594     DOI: 10.3109/14397595.2014.927969

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  2 in total

1.  Clinical usefulness of anti-muscarinic type 3 receptor autoantibodies in patients with primary Sjögren's syndrome.

Authors:  Mahmoud Mona; Stefania Mondello; Joon Young Hyon; Wafaa Saleh; Kyudong Han; Hyo-Jung Lee; You-Jung Ha; Eun Ha Kang; Yun Jong Lee; Seunghee Cha
Journal:  Clin Exp Rheumatol       Date:  2020-10-06       Impact factor: 4.473

2.  A Point-Scoring System for the Clinical Diagnosis of Sjögren's Syndrome Based on Quantified SPECT Imaging of Salivary Gland.

Authors:  Jing Chen; Xia Zhao; Haixia Liu; Sheng Zhou; Yunqiang Yang; Shouxin Li; Zhiqun Xianyu; Yunfeng Han; Guifen Shen; Jinming Li; Cong Ye; Wei Sun; Lingli Dong
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.